Comment on "Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position"
Br J Cancer
.
2021 Feb;124(3):678.
doi: 10.1038/s41416-020-01132-9.
Epub 2020 Nov 3.
Authors
Ali Arshad
1
,
Ashley Dennison
2
3
,
Mark A Taylor
4
5
,
Andrew Cook
6
,
John N Primrose
7
8
Affiliations
1
University Hospital Southampton, Southampton, UK.
2
HPB Surgery, University Hospitals of Leicester, Leicester, UK.
3
Pancreatic Society and the Great Britain and Ireland Hepatopancreatobiliary Association, London, UK.
4
HPB Surgery, Mater Hospital, Belfast, UK.
5
Great Britain and Ireland Hepatopancreatobiliary Association, London, UK.
6
Public Health Medicine, Wessex Institute, Faculty of Medicine, University of Southampton, Southampton, UK.
7
University of Southampton, Southampton, UK. j.n.primrose@soton.ac.uk.
8
Association of Surgeons of Great Britain and Ireland, London, UK. j.n.primrose@soton.ac.uk.
PMID:
33139800
PMCID:
PMC7851378
DOI:
10.1038/s41416-020-01132-9
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19*
Consensus
Humans
Pancreatic Neoplasms* / epidemiology
Pancreatic Neoplasms* / therapy
Pandemics
SARS-CoV-2
United Kingdom / epidemiology